Health
Newer Type 2 diabetes medications have heart and kidney disease benefits, too – Science Codex
DALLAS, Sept. 28, 2020 — Two newer groups of medications prescribed primarily for Type 2 diabetes treatment (SGLT2 inhibitors and GLP-1 receptor agonists) could significantly reduce risks associated with chronic kidney disease (CKD) and heart disease. Based on analyses of the clinical trials through March 2020, a group of leading experts in diabetes, heart failure, kidney disease and cardiometabolic disease believe the medicines should be considered for people with CKD and Type 2 diabetes to pr…
-
Noosa News11 hours agoMan dies in Brisbane crash, women and girl rushed to hospital
-
General20 hours agoProductivity summit ends day two with progress on rules changes to boost housing supply
-
Noosa News23 hours agoGirl charged with attempted murder after foster carer stabbed in Ipswich
-
General21 hours agoSharp rise in airfares push UK inflation higher in July